Search
Disc Medicine Inc
IRONAdd to Watchlist
61.650USD
-1.680-2.65%
Close 10-06 16:00（ET）
2.36BMarket Cap
LossP/E TTM
Disc Medicine Inc (IRON) Stock Price Target & Forecast
Analyst Rating
Based on 13 analysts giving stock ratings to Disc Medicine Inc in the past month.
Buy
5 Strong Buy
8 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
103.167USD+59.92%
IRON Analyst Recommendation Trends
In the current month, IRON has received 8 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IRON average Analyst price target in the last month is 103.167.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
5
5
5
5
5
5
5
5
8
8
8
8
8
8
8
8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
13
13
13
13
13
13
13
Financial Forecasting
Based on analysts' estimates, IRON EPS is projected to reach -1.726 in FY2026Q3, following reported EPS of -1.539 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.74
-1.71
-1.75
-1.73
-1.80
Actual
-1.61
-1.65
-1.54
--
--
Surprise
+7.78%
+3.69%
+11.96%
--
--
FAQs
What is Disc Medicine Inc's price target?
Analysts forecast that Disc Medicine Inc's price target is USD 110.00, with the highest forecast at USD 153.00 and the lowest forecast at USD 85.00.
How have Disc Medicine IncIRON's recent earnings per share performed?
The market expectation was USD -1.54, while Disc Medicine IncIRON's earnings per share (EPS) for the previous quarter was USD -1.65. EPS for the next quarter is expected at USD -1.73.
What is the analyst rating for Disc Medicine Inc?
Based on the ratings of Disc Medicine Inc's stock from 13 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.